ask="0.63"
ask_size="2400"
average_daily_volume="152698"
bid="0.58"
bid_size="400"
book_value="0.73"
change="-0.01"
change_from_200_day_moving_average="-0.71"
change_from_50_day_moving_average="-0.40"
change_from_52_week_high="-1.41"
change_From_52_week_low="0.03"
change_in_percent="-1.83%"
close="0.59"
dividend_pay_date="11/8/2012"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.81"
ebitda="-30.60M"
eps_estimate_current_year="-0.93"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.86"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.63"
high_52_weeks="2.00"
last_trade_date="3/7/2017"
last_trade_price="0.59"
last_trade_size="750"
last_trade_time="4:00pm"
low="0.56"
low_52_weeks="0.56"
market_capitalization="22.80M"
moving_average_200_day="1.30"
moving_average_50_day="0.99"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.17"
open="0.57"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-54.74%"
percent_change_from_50_day_moving_average="-40.28%"
percent_change_from_52_week_high="-70.50%"
percent_change_from_52_week_low="+5.36%"
previous_close="0.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.83"
price_per_sales="2.37"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="0.38"
stock_exchange="NMS"
symbol="AVIR"
volume="155332"
weeks_range_52="0.56 - 2.00"
